Provided by Tiger Trade Technology Pte. Ltd.

Cellectar Biosciences

1.78
-0.0900-4.81%
Post-market: 1.820.0400+2.25%19:30 EDT
Volume:48.04K
Turnover:88.33K
Market Cap:16.82M
PE:-0.81
High:1.98
Open:1.95
Low:1.78
Close:1.87
52wk High:6.52
52wk Low:1.78
Shares:9.45M
Float Shares:9.01M
Volume Ratio:0.63
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2100
EPS(LYR):-8.3544
ROE:-119.57%
ROA:-58.44%
PB:0.56
PE(LYR):-0.21

Loading ...

May 04, 2023

Major Issues Report

Form 8-K - Current report
Mar 16, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 04, 2023

Major Issues Report

8-K - Current report
Dec 02, 2022

Major Issues Report

8-K - Current report
Nov 30, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 23, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 03, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 25, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 25, 2022

Major Issues Report

8-K - Current report
Sep 22, 2022

Major Issues Report

8-K - Current report
Sep 13, 2022

Major Issues Report

8-K - Current report
Aug 05, 2022

Major Issues Report

8-K - Current report
Aug 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans